Deficiency of GPR109a could induce an increase of colonic inflammation in mouse model and administration of the agonist of GPR109a, Niacin, could ameliorate colonic inflammation in a GPR109a dependent manner, further strengthened the effect of butyrate–GPR109a axis in regulating epithelial barrier function. Here, HCAR2 is linked to colitis.